Category: anti-aging

  • Human Longevity strikes a SPAC deal to go public and fuel U.S., global expansion

    Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to […]